FIGURE 1 Given the role of GLP-1 in glycaemic control, the anti-apoptotic, growth-stimulating and insulin secretion-promoting effects on pancreatic -cells, the ability to re-sensitize the cellular insulin-signaling, minor side effects, good tolerance by normoglycemic patients and the fact that GLP-1 does not desensitize, synthetic GLP-1R agonists have been on the market for decades to treat type 2 diabetes mellitus (T2DM) or, more recently, to improve weight loss (Drucker, 2018)
It reverses the livers resistance to insulin, increases glucose utilization by liver tissue cells, and lowers blood glucose levels in circulation, thereby reducing the adverse side effects of chronically high blood glucose levels (Fig
Si se puede comprar sin receta, no se trata de un frmaco GLP-1 propiamente dicho, dice Alan, es otra cosa que se comercializa para apoyar tu produccin endgena de GLP-1"
The medications may also have an ominous side effect thats not often reported
- , - :